1.1 Mortality at 12 months‐ Main analysis |
18 |
9575 |
Risk Ratio (M‐H, Random, 95% CI) |
0.98 [0.93, 1.03] |
1.2 Mortality at 12 months‐ Subgroups Lung vs non‐Lung Cancer |
12 |
4768 |
Risk Ratio (M‐H, Random, 95% CI) |
0.94 [0.86, 1.03] |
1.2.1 Lung Cancer (SCLC or NSCLC) |
6 |
3204 |
Risk Ratio (M‐H, Random, 95% CI) |
0.89 [0.73, 1.08] |
1.2.2 non‐Lung Cancer |
7 |
1564 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.88, 1.03] |
1.3 Mortality at 12 months‐ Subgroups Advanced vs non‐Advanced |
18 |
9575 |
Risk Ratio (M‐H, Random, 95% CI) |
0.98 [0.94, 1.03] |
1.3.1 Advanced cancer |
12 |
6115 |
Risk Ratio (M‐H, Random, 95% CI) |
0.98 [0.93, 1.02] |
1.3.2 Non‐advanced cancer |
8 |
3460 |
Risk Ratio (M‐H, Random, 95% CI) |
0.92 [0.75, 1.12] |
1.4 Mortality at 24 months‐ Main Analysis |
14 |
5229 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.96, 1.01] |
1.5 Mortality at 24 months‐ Subgroups Advanced vs non‐Advanced |
14 |
5229 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.96, 1.01] |
1.5.1 Advanced cancer |
6 |
1554 |
Risk Ratio (M‐H, Random, 95% CI) |
0.98 [0.93, 1.03] |
1.5.2 Non‐advanced cancer |
8 |
3675 |
Risk Ratio (M‐H, Random, 95% CI) |
0.98 [0.93, 1.04] |
1.6 Mortality over duration of study |
15 |
|
Hazard Ratio (IV, Random, 95% CI) |
0.93 [0.84, 1.03] |
1.7 Symptomatic VTE‐ Main analysis |
16 |
9036 |
Risk Ratio (M‐H, Random, 95% CI) |
0.56 [0.47, 0.68] |
1.8 Symptomatic VTE‐ Subgroups Lung vs non‐Lung Cancer |
11 |
8090 |
Risk Ratio (M‐H, Random, 95% CI) |
0.52 [0.43, 0.63] |
1.8.1 Lung Cancer (SCLC or NSCLC) |
6 |
4217 |
Risk Ratio (M‐H, Random, 95% CI) |
0.53 [0.41, 0.68] |
1.8.2 Non‐lung cancer |
7 |
3873 |
Risk Ratio (M‐H, Random, 95% CI) |
0.51 [0.37, 0.70] |
1.9 PE |
14 |
8867 |
Risk Ratio (M‐H, Random, 95% CI) |
0.61 [0.47, 0.80] |
1.10 Symptomatic DVT |
14 |
8867 |
Risk Ratio (M‐H, Random, 95% CI) |
0.46 [0.33, 0.63] |
1.11 Major bleeding‐ Main analysis |
18 |
9592 |
Risk Ratio (M‐H, Random, 95% CI) |
1.30 [0.94, 1.79] |
1.12 Major bleeding‐ Subgroups Lung vs non‐Lung Cancer |
10 |
4163 |
Risk Ratio (M‐H, Random, 95% CI) |
1.62 [1.02, 2.56] |
1.12.1 Lung Cancer (SCLC or NSCLC) |
5 |
3035 |
Risk Ratio (M‐H, Random, 95% CI) |
1.45 [0.77, 2.73] |
1.12.2 Non‐lung cancer |
5 |
1128 |
Risk Ratio (M‐H, Random, 95% CI) |
1.84 [0.94, 3.58] |
1.13 Minor bleeding |
16 |
9245 |
Risk Ratio (M‐H, Random, 95% CI) |
1.70 [1.13, 2.55] |
1.14 Thrombocytopenia |
12 |
5832 |
Risk Ratio (M‐H, Random, 95% CI) |
0.69 [0.37, 1.27] |